In addition, we found that ESCC patients with high ATF3 expression had poor prognosis, and the expression level increased with the progression of ESCC stage, suggesting that ATF3 has the potential to serve as a biomarker. Here, ATF3 is linked to esophageal squamous cell carcinoma.